Forward Health’s $225 Million Series D Financing

Latham & Watkins LLP represented SoftBank Vision Fund 2 in the transaction.

Forward Health, a healthcare system empowering doctors with technology and data to monitor and guide long-term health, has announced US$225 million in Series D funding with participation from SoftBank Vision Fund 2.

The funding will help expand Forward Health’s healthcare system nationwide and introduce new doctor-led programs focused on heart health, cancer detection, COVID-19, stress, anxiety, and weight management. 

Latham & Watkins LLP represented SoftBank Vision Fund 2 in the transaction with an emerging companies team led by Bay Area partners Ben Potter (Picture) and Saad Khanani, with Chicago associate Omar Ammash and Bay Area associate Adam Zuckerman. Advice was also provided on antitrust matters by Washington, D.C. counsel Patrick English; on data and technology transactions by Los Angeles counsel Jia Jia Huang, with associate Nicole Nour; and on data privacy matters by Bay Area counsel Robert Blamires, with Boston associate Kiara Vaughn.

Involved fees earner: Omar Ammash – Latham & Watkins; Robert Blamires – Latham & Watkins; Patrick English – Latham & Watkins; Jia Jia Huang – Latham & Watkins; Saad Khanani – Latham & Watkins; Nicole Nour – Latham & Watkins; Benjamin Potter – Latham & Watkins; Kiara Vaughn – Latham & Watkins; Adam Zuckerman – Latham & Watkins;

Law Firms: Latham & Watkins;

Clients: SoftBank Vision Fund II;

Author: Martina Bellini